Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
The Lupus APTT is a clotting time test that uses a reagent designed to be sensitive to lupus anticoagulant, an antibody that targets phospholipids and proteins involved in blood clotting. It measures how long it takes your blood plasma to form a clot through the intrinsic and common pathways of coagulation.
This test is commonly used as part of a panel to screen for lupus anticoagulant and related antiphospholipid antibodies. It does not diagnose autoimmune disease by itself, but it helps your clinician decide whether additional, more specific tests are needed.
Lupus anticoagulant can slow certain clotting tests in the laboratory while being associated with a higher tendency to form clots in the body. The Lupus APTT helps flag this pattern so your care team can look for antiphospholipid syndrome, a condition linked to blood clots, pregnancy complications, and some autoimmune disorders.
Clinicians may order the Lupus APTT if you have an unexplained prolonged clotting screen, a history of clots, certain types of pregnancy loss, or before procedures when a coagulation abnormality is suspected. Results are interpreted alongside other tests such as dilute Russell viper venom time and specific antibody assays to build a complete picture.
A prolonged Lupus APTT can suggest the presence of lupus anticoagulant, but it is not specific. Mixing studies, confirmatory assays that add excess phospholipid, and companion tests are often needed to distinguish an inhibitor like lupus anticoagulant from a factor deficiency or medication effect. Your clinician will consider your medications, symptoms, and history when interpreting the result.
If your result is unexpected, you may be asked to repeat testing when you are well and off interfering drugs, or to complete a full antiphospholipid antibody workup. If lupus anticoagulant is confirmed, your care plan may include monitoring, risk assessment for clots, and discussion of preventive strategies tailored to your situation, including considerations for surgery or pregnancy.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Heparin, low molecular weight heparin, and direct oral anticoagulants can prolong phospholipid-dependent tests and mimic or mask lupus anticoagulant effects.
Warfarin and severe vitamin K deficiency reduce clotting factors and may prolong the test, complicating interpretation of inhibitor screening.
Underfilled citrate tubes, delayed processing, hemolysis, or improper storage can alter clotting times and lead to misleading results.
Very high red blood cell levels change the citrate-to-blood ratio, which can artifactually prolong clotting assays unless the tube is adjusted.
Infection, surgery, or active thrombosis can transiently affect coagulation proteins and lupus anticoagulant expression, impacting results.
Physiologic changes and medications containing estrogen can shift coagulation balance and may influence lupus anticoagulant screening assays.
References